BFLY vs. LMAT, LIVN, ENOV, NVCR, CNMD, WRBY, CDRE, KMTS, PLSE, and LQDA
Should you be buying Butterfly Network stock or one of its competitors? The main competitors of Butterfly Network include LeMaitre Vascular (LMAT), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), CONMED (CNMD), Warby Parker (WRBY), Cadre (CDRE), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry.
Butterfly Network vs.
LeMaitre Vascular (NASDAQ:LMAT) and Butterfly Network (NYSE:BFLY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.
LeMaitre Vascular currently has a consensus target price of $98.14, suggesting a potential upside of 8.46%. Butterfly Network has a consensus target price of $3.00, suggesting a potential upside of 28.48%. Given Butterfly Network's stronger consensus rating and higher probable upside, analysts clearly believe Butterfly Network is more favorable than LeMaitre Vascular.
LeMaitre Vascular has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.
In the previous week, LeMaitre Vascular had 1 more articles in the media than Butterfly Network. MarketBeat recorded 10 mentions for LeMaitre Vascular and 9 mentions for Butterfly Network. LeMaitre Vascular's average media sentiment score of 0.97 beat Butterfly Network's score of 0.82 indicating that LeMaitre Vascular is being referred to more favorably in the media.
LeMaitre Vascular has a net margin of 19.40% compared to Butterfly Network's net margin of -129.25%. LeMaitre Vascular's return on equity of 13.15% beat Butterfly Network's return on equity.
LeMaitre Vascular received 508 more outperform votes than Butterfly Network when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 70.00% of users gave Butterfly Network an outperform vote.
LeMaitre Vascular has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.6, indicating that its stock price is 160% more volatile than the S&P 500.
84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 37.8% of Butterfly Network shares are owned by institutional investors. 10.8% of LeMaitre Vascular shares are owned by company insiders. Comparatively, 27.3% of Butterfly Network shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
LeMaitre Vascular beats Butterfly Network on 15 of the 19 factors compared between the two stocks.
Get Butterfly Network News Delivered to You Automatically
Sign up to receive the latest news and ratings for BFLY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Butterfly Network Competitors List
Related Companies and Tools
This page (NYSE:BFLY) was last updated on 5/1/2025 by MarketBeat.com Staff
